Dr. Sonja Gabriele Schuetz M.D.

Recommended Articles

• Drug Exondys 51 Helps to Preserve Lung Function in Duchenne

  Duchenne muscular dystrophy is a rare genetic condition that affects one in 3500-5000 male children. It is a condition in which the muscles fail to produce enough dystrophin due to a genetic defect; dystrophin is essential to protect muscles from wear and tear. The deficit of dystrophin causes...

• Pristiq vs. Effexor

  Pristiq and Effexor are medications that have similar compositions and are produced by the same manufacturing company. Pristiq (desvenlafaxine) is an antidepressant, which has been recently approved by the FDA. The composition of Pristiq is similar to Wyeth’s existing antidepressant. The patent...

• Drug for Opioid Addiction to Treat Multiple Sclerosis

  Recently, there has been a lot of discussion about the opioid crisis. However, one of these medications may have a silver lining for MS. This might serve as a treatment for the disease, or it may simply delay the progressive effects. Either way, any progress is important for those suffering from...

• Alzheimer's Breakthrough: Study Has Found a Change in Protein Can Reverse Alzheimer's Damage

  Alzheimer’s is a progressive brain disorder that has no cure. When a person develops the disease, they develop amyloid plaques as well as neurofibrillary tangles. As the condition worsens, the neurons deteriorate, eventually dying out.Both early and late onset Alzheimer's disease have a genetic...

• What are the Causes and Symptoms of Meningitis?

  Inflammation of the meninges, the delicate membrane covering brain and spinal cord, is called as meningitis. There are different types of meningitis based on the cause of the disease. Some of these forms have very mild symptoms and may resolve on its own, while some other forms are serious and life...

• Subtle Changes in Speech Can Signify Early Dementia, Study Says

  Filler words, rambling, repetition, and vague word choices could signal a future diagnosis of Alzheimer’s, according to new research presented at the Alzheimer’s Association in July 2017.During the London conference, Professor Kimberly Mueller from University of Wisconsin-Madison outlined these...